about
Microscale acoustofluidics: Microfluidics driven via acoustics and ultrasonicsModels of chronic obstructive pulmonary diseaseMolecular mechanisms of severe acute respiratory syndrome (SARS)Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug deliveryEmbryonic chicken trachea as a new in vitro model for the investigation of mucociliary particle clearance in the airwaysCylinders vs. spheres: biofluid shear thinning in driven nanoparticle transport.Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport.Nanomedicine in pulmonary deliveryPreparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy.Following the concentration of polymeric nanoparticles during nebulization.Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse modelInhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).Pulmonary drug delivery strategies: A concise, systematic reviewNeurogenic mechanisms in bronchial inflammatory diseases.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translationInterferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells.Exploring targeted pulmonary delivery for treatment of lung cancer.Delivery of antibiotics to the respiratory tract: an update.Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.Passive lung-targeted drug delivery systems via intravenous administration.Newer devices and improved formulations of inhaled insulin.Clinical pharmacokinetics of inhaled antimicrobials.Clinical translation of RNAi-based treatments for respiratory diseases.Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol.Amphiphilic, low molecular weight poly(ethylene imine) derivatives with enhanced stability for efficient pulmonary gene delivery.Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells.Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapyDevelopment and evaluation of inhalational liposomal system of budesonide for better management of asthmaInhalational system for Etoposide liposomes: formulation development and in vitro deposition.Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique.Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer.Understanding the mutual impact of interaction between hydrophobic nanoparticles and pulmonary surfactant monolayer.The advantages of pulmonary delivery of therapeutic siRNA.Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery.Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery.A review on recent technologies for the manufacture of pulmonary drugs.Targeted inhibition of Gq signaling induces airway relaxation in mouse models of asthma.A compartment-quasi-3D multiscale approach for drug absorption, transport, and retention in the human lungs.
P2860
Q21563659-CF11A63D-E752-439C-A8C3-2D329A77ED0BQ24798450-851D2DB5-ABC9-4025-8980-6B9D94D27934Q24799739-99C28419-33C5-4C3E-A236-C850B11D902EQ26766552-60CA7820-8A9A-4FED-A91D-2916169DC4A0Q30497327-4F767952-ADD4-4499-953E-0C38B412A728Q30559209-6AAE0772-F752-4A0C-BBAF-2A9770200A47Q33198362-5AA03A23-4571-409E-884D-8928A1BEBB7FQ33572981-5B7BD37E-3331-413F-8A13-D3B2B1E4B630Q34114591-97582804-C2E0-4AFA-A2B1-EECB75BD28FBQ34340755-FEB82E80-AB41-4946-BB21-CEC8D6B232FCQ34478750-A25E1992-91CB-4735-829E-DA6752687B2FQ34894092-84961DDA-53E6-42AB-96C1-3221C15C1904Q35016089-B2A3A6F6-2715-4B8E-8FDA-09C8F15DAA99Q35746468-75604815-F774-4242-9BA7-08595B12E2EAQ35907064-4F54A0CE-1785-449F-8758-B077A18ECED8Q36598433-5BB0C3C2-EB7C-405F-A4AA-183F681DDBE1Q36740258-CD732AEF-72B3-4159-A9D6-D1A170C1B050Q36942012-DCCEF56C-FC80-4C9F-930A-0CA91871E487Q37564542-23F7304E-2689-4A49-B2B9-CF1831D834FAQ37602017-89D0530B-C253-41FD-96BF-38BDF0CECD6EQ38075609-42356B53-0152-4F14-875E-7058C08CEB4CQ38285092-CCABA7A2-B2AE-4D8D-9C8E-7E6E76A22A74Q38367260-5A9CAC58-EE4D-4ED9-9008-311EB879C693Q38383297-C5482B39-7A5C-44EE-854F-ECB6EE8CE04BQ38498038-48F5588E-35C8-4613-A7A4-B69EC62F148DQ39034958-5008F582-BFEE-4F12-894D-0725F1579324Q39594809-61B3F011-86C8-49C1-B699-42E12C7A9149Q39664012-DA1FC71E-74E8-4FAB-A15A-D6A0A5C7F3D2Q39727842-D41AB4EB-B850-4D00-A0FA-9A2CC68BAACAQ41576732-59E20EA3-0D9F-45AE-834C-F051B0F4D47EQ42113530-8DD511E0-BDA5-4864-BB4F-4016EE69CCE8Q42168488-FC3E7DBF-E20E-4BEC-B7AF-79C55CA464A6Q43120677-2B8B8997-47D1-4BC8-8268-C53ED681C285Q44454078-DF6B4C1C-8826-45AD-9FC3-4BCED1A4B460Q45876125-7151D852-6109-4468-B10B-A40A82FA909EQ45886809-EFDC33D0-382A-4BF7-8E70-22E79DE7FC1EQ47210467-69D9504F-2A80-45D2-B80C-26E989599B94Q47272028-C3E4728F-1DF1-405B-BDF1-5CA76A7F5CD2Q47774087-438A6613-B1BA-4727-B94C-D10EDB2CB2EBQ48355199-38896DA6-44BF-45A8-A08D-EEB1EBBEFCEA
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Fundamentals of pulmonary drug delivery.
@ast
Fundamentals of pulmonary drug delivery.
@en
type
label
Fundamentals of pulmonary drug delivery.
@ast
Fundamentals of pulmonary drug delivery.
@en
prefLabel
Fundamentals of pulmonary drug delivery.
@ast
Fundamentals of pulmonary drug delivery.
@en
P2093
P356
P1433
P1476
Fundamentals of pulmonary drug delivery
@en
P2093
P304
P356
10.1053/RMED.2002.1457
P577
2003-04-01T00:00:00Z